HEYWOOD FAMILY PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: L81085 | BRISTOL, BS20 0DL
Showing results 101-150 of 492
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Montelukast | 272 | 9,842 | £479 | -60.3% ▼ |
| Venlafaxine | 269 | 12.5K | £2.0K | -68.2% ▼ |
| Ferrous fumarate | 267 | 20.7K | £803 | -63.2% ▼ |
| Atenolol | 257 | 14.1K | £403 | -57.4% ▼ |
| Ispaghula husk | 254 | 14.0K | £2.4K | +92.8% ▲ |
| Bendroflumethiazide | 253 | 12.9K | £209 | -67.3% ▼ |
| Typhoid | 253 | 253 | £2.5K | +181.0% ▲ |
| Duloxetine hydrochloride | 250 | 10.8K | £1.2K | -60.7% ▼ |
| 249 | 33.0K | £880 | +263.5% ▲ | |
| Clotrimazole | 248 | 5,940 | £379 | +155.9% ▲ |
| Umeclidinium bromide/vilanterol | 242 | 369 | £11.3K | +24.1% ▲ |
| Memantine hydrochloride | 242 | 7,602 | £918 | -26.7% ▼ |
| Estriol | 240 | 4,309 | £1.6K | +12.8% ▲ |
| Aciclovir | 238 | 12.2K | £592 | +60.0% ▲ |
| Isosorbide mononitrate | 233 | 11.9K | £1.9K | -64.7% ▼ |
| Hyoscine butylbromide | 230 | 14.3K | £1.1K | -1.3% vs avg |
| Oxycodone hydrochloride | 222 | 39.9K | £2.5K | -13.3% ▼ |
| Brinzolamide | 222 | 1,705 | £1.2K | +70.9% ▲ |
| Empagliflozin | 221 | 9,898 | £12.2K | -64.7% ▼ |
| Pravastatin sodium | 216 | 5,831 | £294 | -33.5% ▼ |
| Lactulose | 212 | 113.5K | £1.0K | -35.6% ▼ |
| Mebeverine hydrochloride | 211 | 18.1K | £730 | -32.0% ▼ |
| Isophane insulin | 211 | 2,185 | £9.1K | +99.9% ▲ |
| 211 | 2,940 | £1.8K | -68.2% ▼ | |
| 211 | 21.0K | £1.3K | -2.4% ▼ | |
| Insulin aspart | 208 | 1,663 | £8.8K | -45.4% ▼ |
| Fexofenadine hydrochloride | 201 | 11.2K | £477 | -76.4% ▼ |
| Fluticasone propionate (Inhalation) | 199 | 308 | £5.0K | -48.6% ▼ |
| Fluticasone/umeclidinium/vilanterol | 197 | 289 | £12.1K | -16.0% ▼ |
| 190 | 251 | £10.9K | -38.8% ▼ | |
| Methenamine hippurate | 188 | 10.2K | £2.7K | +106.7% ▲ |
| Other emollient preparations | 188 | 88.8K | £1.3K | -68.7% ▼ |
| Mesalazine (Systemic) | 186 | 23.7K | £12.4K | -22.4% ▼ |
| Clobetasone butyrate | 180 | 8,865 | £801 | -11.8% ▼ |
| 178 | 192 | £1.0K | -24.6% ▼ | |
| Lamotrigine | 177 | 13.0K | £1.9K | -70.0% ▼ |
| Insulin glargine | 174 | 1,105 | £10.1K | -38.7% ▼ |
| Mirabegron | 170 | 8,080 | £7.4K | -57.7% ▼ |
| Lidocaine hydrochloride | 169 | 1,120 | £642 | -2.0% ▼ |
| Olanzapine | 167 | 5,577 | £878 | -54.9% ▼ |
| Medroxyprogesterone acetate | 160 | 165 | £897 | +32.5% ▲ |
| Sumatriptan succinate | 158 | 1,454 | £1.1K | -55.4% ▼ |
| Trimethoprim | 155 | 3,732 | £227 | -24.1% ▼ |
| Sacubitril/valsartan | 152 | 10.4K | £16.9K | -36.5% ▼ |
| Warfarin sodium | 150 | 8,545 | £314 | -68.2% ▼ |
| Other health supplement preparations | 150 | 4,876 | £603 | +215.8% ▲ |
| Paroxetine hydrochloride | 148 | 5,304 | £308 | -20.7% ▼ |
| Cyclizine hydrochloride | 145 | 6,544 | £232 | -10.1% ▼ |
| Trazodone hydrochloride | 144 | 6,461 | £259 | -29.5% ▼ |
| Hepatitis A | 143 | 143 | £2.6K | +88.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.